NASDAQ: RCKT
Rocket Pharmaceuticals Inc Stock Ownership - Who owns Rocket Pharmaceuticals?

Insider buying vs selling

Have Rocket Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Jonathan David SchwartzChief Medical Gene Therapy Officer2025-02-256,532$10.58
$69.11kSell
Martin WilsonGeneral Counsel2025-02-213,222$10.58
$34.09kSell
Gaurav ShahCEO2025-02-2116,303$10.58
$172.49kSell
Kinnari PatelPresident Head of RD and Chief Operating Officer2025-02-216,078$10.58
$64.31kSell
John MilitelloVice President of Finance Treasurer Principal Accounting Officer2025-02-212,737$10.58
$28.96kSell
John MilitelloVice President of Finance Treasurer Principal Accounting Officer2025-01-23896$10.38
$9.30kSell
Jonathan David SchwartzChief Medical Gene Therapy Officer2024-11-213,097$13.05
$40.42kSell
John MilitelloVice President of Finance Treasurer Principal Accounting Officer2024-11-211,224$13.05
$15.98kSell
Kinnari PatelPresident Head of RD and Chief Operating Officer2024-11-214,588$13.05
$59.89kSell
Gaurav ShahCEO2024-11-2111,091$13.05
$144.78kSell

1 of 4

RCKT insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when RCKT insiders and whales buy or sell their stock.

RCKT Shareholders

What type of owners hold Rocket Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Rtw Investments LP31.53%33,617,724$294.49MInsider
Rtw Investments LP16.59%17,687,772$154.94MInstitution
Roderick Wong15.26%16,272,635$142.55MInsider
Wellington Management Group LLP13.13%13,995,177$122.60MInstitution
Blackrock Inc6.66%7,097,287$62.17MInstitution
Vanguard Group Inc6.17%6,577,595$57.62MInstitution
Maverick Capital Ltd4.88%5,198,900$45.54MInstitution
Westfield Capital Management Co LP4.42%4,714,610$41.30MInstitution
Citadel Advisors LLC3.87%4,122,824$36.12MInstitution
Janus Henderson Group PLC3.76%4,004,039$35.08MInstitution

1 of 3

RCKT vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
RCKT59.61%40.39%Net SellingNet Selling
NTLA71.84%28.16%Net SellingNet Selling
PHVS82.32%0.00%
XNCR70.29%29.71%Net SellingNet Selling
REPL65.29%34.71%Net Selling

Rocket Pharmaceuticals Stock Ownership FAQ

Who owns Rocket Pharmaceuticals?

Rocket Pharmaceuticals (NASDAQ: RCKT) is owned by 102.82% institutional shareholders, 69.67% Rocket Pharmaceuticals insiders, and 0.00% retail investors. Rtw Investments LP is the largest individual Rocket Pharmaceuticals shareholder, owning 33.62M shares representing 31.53% of the company. Rtw Investments LP's Rocket Pharmaceuticals shares are currently valued at $294.49M.

If you're new to stock investing, here's how to buy Rocket Pharmaceuticals stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.